Patient Screening Articles
-
Emerging therapy for HFpEF: SGLT2 inhibitors
Recent clinical trials investigating sodium-glucose cotransporter 2 inhibitors (SGLT2i) have highlighted that this drug is highly effective in treating patients with heart failure with preserved ejection fraction (HFpEF). HFpEF is a complex disease which accounts for more than half of all heart failure (HF) hospital admissions and is an increasing disease burden. [1] The prevalence of HFpEF is ...
-
New Screening Solution Offers Hope in the Battle Against TB
In recent years, a number of ‘old’ diseases have re-emerged as significant threats to world health, driven by factors such as population migration and modern transportation. Of particular concern is the increase in the incidence of tuberculosis (TB) infection, a highly contagious disease spread through the air when infected people cough, sneeze or spit. According to statistics ...
-
Navigating Cancer’s, Dr. Amila Patel, Provides Insight on Racial Disparities in Recent Cancer Treatment Study
Navigating Cancer, Chief Clinical & Strategy Officer, Dr. Amila Patel, PharmD, BCOP, recently presented data on key findings from a recent abstract with Duke Health revealing racial disparities among head and neck cancer populations at the 2022 American Society of Clinical Oncology conference. Our research, along with our partners at Duke Health, found there were significant health care ...
-
InfraScan Inc. Announces Publication of the Largest Study to date for TBI Diagnosis Utilizing NIRD
InfraScan, a medical device firm specializing in traumatic brain injury diagnostic products, announced the publication of the largest U.S. study to date using a near-infrared device (NIRD) to detect bleeds resulting from Traumatic Brain Injuries (TBI). This independent study was published in the Journal of Neurotrauma on 2 Aug 2022. https://doi.org/10.1089/neu.2021.0342. “We wish to thank ...
-
Digital Endpoints in Clinical Trials for Neurology: Benefits and Impediments to Adoption
In addition to the pandemic, the digitization of healthcare is rapidly shifting clinical trials from analog to hybrid or fully decentralized clinical trials, catalyzing the development and implementation of digital health technologies to support clinical research. Digital endpoints not only support the decentralization of clinical trials but also provide a means to collect more sensitive, ...
-
Case Study: Leading Interventionalist Makes the Move to mild® and Helps Patient (67) Find Lasting Relief
mild® Provider, Dr. Shawn Puri | Double Board-Certified Anesthesiologist and Pain Medicine Specialist | Relievus Pain Management This case study highlights a female patient, age 67, with debilitating back pain that prevented her from completing tasks of daily living and decreased her quality of life. Despite multiple interventions, including epidural steroid injections (ESIs) and medication ...
-
Deliver Clinical Trials On Time and Within Budget By Addressing this One Problem
Annual planning is an opportunity to fix this long-standing clinical operations issue At the beginning of many pharma companies’ financial year, an annual planning process occurs. This presents an opportunity for stakeholders to align on short-, mid-, and long-term goals. Clinical stage pharma companies focus on clinical-trial related goals. These include completing ongoing clinical ...
-
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic conditions such as dementia, diabetes, heart and respiratory disease, the health impact during traumatic periods such as this is magnified. The COVID-19 pandemic has disrupted our ...
-
HRS 2017: New implantable string subcutaneous defibrillator shows promise for sudden cardiac death prevention
The use of a novel implantable string subcutaneous defibrillator (ISSD, Newpace) that has no can, and has been designed to be placed without the need for a surgical pocket, may allow improved patient compliance and aesthetics, is less invasive, and has optimal implantation time. The results from a first-in-man feasibility study on subcutaneous defibrillation utilising an integrated flexible ...
By NewPace Ltd.
-
Novel String-Shaped Subcutaneous ICD Proves Effective in Patients
May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSD), a flexible, string-shaped and first-ever rechargeable implantable cardioverter-defibrillator (ICD). This is the first-in-man study to report on the feasibility of the innovative device and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual ...
By NewPace Ltd.
-
Low doses of γ–radiation induce consistent protein expression changes in human leukocytes
Twenty percent of cancer patients experience adverse effects after radiotherapy. The therapeutic doses are adjusted to the most sensitive individuals, resulting in a suboptimal dose for many patients. At present there is no screening system available to predict individual radiosensitivity. The main aim of this study is to investigate differences in protein expression pathways induced by low doses ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you